40.6

Million Dollars

in 2020 revenue from FC2

17.66

Million Dollars

worth of FC2 prescription in US and globally

150

Countries

The number of countries in which FC2 is sold

View Our Analysis

The Path to Drawdown: Contraceptives

Approximately 225 million women in lower-income countries say they lack the ability to choose whether and when to become pregnant. That leads to ~75 million unintended pregnancies each year. There's also a similar deficiency in contraceptives in high-income countries. In the United States, for example, nearly half of all pregnancies are unintended.

Securing the right to voluntary, high-quality family planning services and contraception around the world would have significant positive impacts on the health, welfare, and life expectancy of both women and their children.

Contraceptives, family planning and resources for women's health would also hugely benefit the environment. Every person in the world consumes resources and causes emissions throughout their life. If contraceptives are widely provided and women's health are secured, a more stable population size could help avoid up to 85.42 gigatons of greenhouse gases between 2020 and 2050.

What We Want to See Improve

Disclose Emissions from Direct Operations

FC2 is manufactured (p. 27) in a single facility, so we don't expect Veru's direct emissions to be very large. Still, we want to see Veru disclose key sustainability metrics like their greenhouse gas emissions. We urge them to publish an annual sustainability report that includes these metrics so that investors can assess the company's carbon footprint.

Enhance Supplier Transparency

Veru reports (p. 27) that they rely on one nitrile polymer supplier to manufacture their FC2, but doesn't provide any further information on this supplier. We'd like Veru to enhance their transparency around their supplier and their carbon footprint and energy use.

Related Birth Control Stocks in the Climate Index

View All Climate Index Stocks →

Allocated Company Description

0.03%

Veru, Inc. (VERU)

Very makes female condoms used by the United Nations that protect against unintended pregnancies and STIs. Women’s health is a valuable Drawdown solution

0.02%

Agile Therapeutics (AGRX)

Agile offers a contraceptive patch that gives women the right to family planning. Family planning is a key Drawdown solution for sustainability

0.02%

Evofem Biosciences, Inc. (EVFM)

Evofem makes a hormone-free contraceptive vaginal gel that gives women control over their reproductive health. Women’s health is a key Drawdown solution

Attend Our Next Webinar

Attend Our Next Webinar

Join our next Sustainable Investing 101 webinar, get our favorite DIY options, and walk through how we build our portfolios.

Register
Get Our Newsletter

Get Our Newsletter

Go a level deeper with us and investigate the potential impacts of climate change on investments like your retirement account.

Talk To A Human

Talk To A Human

Joining a new investment service can be intimidating. We’re here for you. Click below to email us a question or book a quick call.

Ask a Question